Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2008-05-13
2008-05-13
Sitton, Jehanne S (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S091200
Reexamination Certificate
active
07371522
ABSTRACT:
The present invention provides a method of screening subjects for disease risk. The method comprises determining the serotonin transporter gene promoter genotype of a subject. The serotonin transporter gene promoter genotype is used to indicate whether or not the subject is at increased risk of disease. The method is particularly adapted to screening for risk of disease in response to stress, and accordingly can be used to indicate interventions that manage stress, and hence reduce disease risk, in susceptible or higher-risk individuals.
REFERENCES:
patent: 5418162 (1995-05-01), Blakely et al.
patent: 6653073 (2003-11-01), Comings et al.
patent: WO 99/42619 (1999-08-01), None
Persico et al; American Journal of Medical Genetics, vol. 96, pp. 123-127, 2000.
Kunugi et al; American Journal of Medical Genetics, vol. 96, pp. 307-309, 2000.
Arinami et al; Thrombosis Haemostasis, vol. 81, pp. 853-856, Jun. 1999.
Grassi et al; Circulation, vol. 90, pp. 248-253, 1994.
Kendler et al; Arch. Gen. Psychiatry, vol. 62, May 2005, pp. 529-535.
Williams et al; Neuropsychopharmacology, 2003, vol. 28, pp. 533-541.
Yeo et al; Gut, 2004, vol. 53, pp. 1452-1458.
Wurtman, R.J. Metabolism Clinical and Experimental, vol. 54, pp. 16-19, 2005.
Rozanski et al; Circulation, vol. 99, pp. 2192-2217; 1999, see abstract.
Hanna et al; Neuropsychopharmacology, vol. 18, Feb. 1998, pp. 102-111.
Gabe et al; Molecular Psychiatry vol. 10:220-224; 2005.
Arinami, Tadao, et al., A Synergistic Effect of Serotonin Transporter Gene Polymorphism and Smoking in Association with CHD,Thromb. Haemost., vol. 81, No. 6, pp. 853-856 (Jun. 1999).
Rozanski et al. “Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy”Circulation99:2192-2217 (1999).
Kamarck et al. “Exaggerated Blood Pressure Responses During Mental Stress Are Associated With Enhanced Carotid Atherosclerosis in Middle-Aged Finnish Men”Circulation96:3842-3848 (1997).
Matthews et al. “Stress-Induced Pulse Pressure Change Predicts Women's Carotid Atherosclerosis”Stroke29:1525-1530 (1998).
Everson et al. “Stress-Induced Blood Pressure Reactivity and Incident Stroke in Middle-Aged Men”Stroke32:1263-1270 (2001).
Everson et al. “Anger Expression and Incident Stroke: Prospective Evidence From the Kuopio Ischemic Heart Disease Study”Stroke30:523-528 (1999).
Coto et al. “5-Hydroxytryptamine 5HT2Areceptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction”Clinical Science104:241-245 (2003).
Fumeron et al. “Serotonin Transporter Gene Polymorphism and Myocardial Infarction”Circulation105:2943-2945 (2002).
Higley et al. “Low Central Nervous System Serotonergic Activity Is Traitlike and Correlates with Impulsive Behavior”Annals New York Academy of Sciences836-36-56 (1997).
Lesch et al. “Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region”Science274:1527-1531 (1996).
Lynch et al. “Does Low Socioeconomic Status Potentiate The Effects of Heightened Cardiovascular Responses to Stress on the Progression of Carotid Atherosclerosis?”American Journal of Public Health88(3):389-394 (1998).
Nordin et al. “Acid Monoamine Metabolites in the CSF of Healthy Controls Punctured Without Preceding Strict Bedrest: A Retrospective Study”J. Psychiat. Res.30(2):127-133 (1996).
Roy et al. “Acting Out Hostility in Normal Volunteers: Negative Correlation With Levels of 5HIAA in Cerebrospinal Fluid”Psychiatry Research24:187-194 (1988).
Smeraldi et al. “Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine”Molecular Psychiatry3(6):508-511 (1998).
Williams et al. “Central Nervous System Serotonin Function and Cardiovascular Responses to Stress”Psychosomatic Medicine63:300-305 (2001).
Duke University
Myers Bigel Sibley & Sajovec P.A.
Sitton Jehanne S
LandOfFree
Use of polymorphism of the serotonin transporter gene... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of polymorphism of the serotonin transporter gene..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of polymorphism of the serotonin transporter gene... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2748777